Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fengjuan Shi
Observed names:
Feng-Juan Shi,
Shi, Fengjuan
Institution:
Jiangsu Provincial Center for Disease Control and Prevention
Observed institutions:
Jiangsu Provincial Center for Disease Control and Prevention,
National Health Commission of the People's Republic of China
ORCID:
0009-0005-4601-6539
Observed ORCID:
0009-0005-4601-6539
OpenAlex ID:
A5063228983
Rapid Detection of IgM Antibodies against the SARS-CoV-2 Virus via Colloidal Gold Nanoparticle-Based Lateral-Flow Assay
2020
·
Chao Huang
, Tian Wen
, et al.
·
ACS Omega
·
356
Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial
2022
·
Jing-Xin Li
, Shi-Po Wu
, et al.
·
The Lancet Respiratory Medicine
·
183
PDF
Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial
2022
·
Jingxin Li
, Lihua Hou
, et al.
·
Nature Medicine
·
159
PDF
Development of a lateral flow immunoassay strip for rapid detection of IgG antibody against SARS-CoV-2 virus
2020
·
Tian Wen
, Chao Huang
, et al.
·
The Analyst
·
146
Association of viral load with serum biomakers among COVID-19 cases
2020
·
Fengjuan Shi
, Tao Wu
, et al.
·
Virology
·
86
PDF
Safety and Immunogenicity of Aerosolised Ad5-nCoV or Intramuscular Ad5-nCoV or Inactivated COVID-19 Vaccine Coronavac Given as the Second Booster Following Three Doses of CoronaVac: A Multicentre, Open-Label, Phase 4, Randomized Trial
2022
·
Rong Tang
, Hui Zheng
, et al.
·
The Lancet Respiratory Medicine
·
66
PDF
Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial
2022
·
Pengfei Jin
, Xiling Guo
, et al.
·
PLoS Medicine
·
46
Heterologous prime-boost immunization with CoronaVac and Convidecia
2021
·
Jingxin Li
, Lihua Hou
, et al.
·
medRxiv
·
31
PDF
Rapid detection of severe fever with thrombocytopenia syndrome virus (SFTSV) total antibodies by up‐converting phosphor technology‐based lateral‐flow assay
2019
·
Chao Huang
, Qiaozhen Wei
, et al.
·
Luminescence
·
25
Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice
2015
·
Li Zhang
, Jing Lu
, et al.
·
Viruses
·
15
PDF
Immunogenicity and safety of heterologous immunisation with Ad5-nCOV in healthy adults aged 60 years and older primed with an inactivated SARS-CoV-2 vaccine (CoronaVac): a phase 4, randomised, observer-blind, non-inferiority trial
2023
·
Peng-Fei Jin
, Xi-Ling Guo
, et al.
·
The Lancet Regional Health - Western Pacific
·
13
PDF
Saliva as a source of reagent to study human susceptibility to avian influenza H7N9 virus infection
2018
·
Ming Tan
, Lunbiao Cui
, et al.
·
Emerging Microbes & Infections
·
12
PDF
Development of a double‐antibody sandwich ELISA for detection of SARS‐CoV‐2 variants based on nucleocapsid protein‐specific antibodies
2024
·
Hai Lv
, Fengjuan Shi
, et al.
·
Microbiology and Immunology
·
4
Rapid and quantitative detection of Shiga toxin1 and Shiga toxin2 based on multiple targets UPT‐LF assay
2020
·
Qiaozhen Wei
, Qiushi Hu
, et al.
·
Engineering in Life Sciences
·
4
PDF
Heterologous CoronaVac plus Ad5-nCOV versus homologous CoronaVac vaccination among elderly: a phase 4, non-inferiority, randomized study
2022
·
Pengfei Jin
, Jingxin Li
, et al.
·
medRxiv
·
3
PDF
Effect of monkeypox virus B14R protein fragments binding to IL-1β on apoptosis in HeLa cells
2025
·
Xiaojuan Zhu
, Yunfeng Shan
, et al.
·
Virology Journal
·
1
PDF
Safety and Immunogenicity of Heterologous Boost Immunisation With an Aerosolized Ad5-nCoV After Two-Dose Priming With an Inactivated SARS-CoV-2 Vaccine CoronaVac in Adults: A Randomised, Open-Label, Parallel-Control Trial
2022
·
Jing-Xin Li
, Shi-Po Wu
, et al.
·
SSRN Electronic Journal
·
1
Establishment of a double-antibody sandwich ELISA for the detection of shiga toxin type II in shiga toxin-producing Escherichia coli infection
2016
·
Fengjuan Shi
, Xiaoyan Zeng
, et al.
·
Zhonghua weishengwuxue he mianyixue zazhi
·
1
Preparation and characterization of the affinity and neutralization abilities of human monoclonal antibodies against bunyavirus SFTSV glycoprotein C
2026
·
Jingxian Liu
, Yuhan Ding
, et al.
·
Infectious Medicine
Discovery of human antibody specific to the spike glycoprotein subunit 2 of SARS-CoV-2 and characterization of its broad-spectrum neutralizing activity
2026
·
Ying Chi
, Huimin Yin
, et al.
·
Infectious Medicine
PDF
Saliva as a source of reagent to study human susceptibility to avian influenza H7N9 virus infection
2019
·
Tan, Ming
, Cui, Lunbiao
, et al.
·
Figshare
[Expression and identification of enterohemorrhagic Escherichia coli O157:H7 Shiga toxin1A subunit].
2014
·
Mingming Huang
, Xiaoyan Zeng
, et al.
·
PubMed
Studies of immune procedure of refrigerated and irradiated Schistosoma japonicum larva vaccine.
1990
·
Sai Xu
, Fengjuan Shi
, et al.
·
Zhongguo shouyi ke-ji
Show more works
View as search
Works count:
24
Citation count:
1,335
H-index:
12
I10-index:
13
Year
Topic
Type